Latest news with #NeuroBlu
Associated Press
4 days ago
- Business
- Associated Press
Iris Telehealth and Holmusk Announce Strategic Partnership to Advance Data-Driven Mental Health Care
Holmusk's NeuroBlu Platform and Iris Insights: Powering Real-World Evidence to Deliver Patient Outcomes and Value-Based Care AUSTIN, Texas, June 4, 2025 /PRNewswire/ -- Iris Telehealth, a leading provider of telepsychiatry services, and Holmusk, a global leader in real-world evidence and data analytics for behavioral health, today announced a strategic partnership that brings together two advanced AI platforms to transform mental health care through clinical real-world data and localized insights. The groundbreaking collaboration integrates Holmusk's NeuroBlu platform with Iris Insights, Iris Telehealth's business intelligence platform, creating a solution that provides healthcare organizations with behavioral health data specific to their local markets. This integration enables organizations to identify at-risk patient populations through advanced risk stratification capabilities, all accessible through an intuitive dashboard within the Iris Insights ecosystem. Key objectives of the partnership include developing and evaluating programs that use data to demonstrate improved outcomes and customer value and enhancing the prediction of patient risk using robust mental health data and applying natural language processing (NLP) as well as artificial intelligence (AI). 'This partnership with Holmusk represents a significant leap forward in our mission to transform behavioral healthcare delivery,' said Andy Flanagan, CEO of Iris Telehealth. 'By integrating Holmusk's world-class NeuroBlu platform into our Iris Insights system, we're empowering healthcare organizations with the real-world evidence and analytics they need to make informed decisions, improve patient outcomes, and build truly sustainable behavioral health programs.' Holmusk's NeuroBlu AI platform will provide the analytical foundation for enhanced predictive modeling and data-driven insights within the Iris Insights ecosystem. This capability will be particularly valuable for health systems seeking to expand their behavioral health services while managing costs and improving clinical outcomes through localized, data-driven insights. 'This partnership brings together two complementary strengths - deep data science capabilities and direct clinical delivery - to drive meaningful innovation in behavioral health,' said Nawal Roy, CEO at Holmusk. 'Together, we're creating new opportunities for healthcare organizations to demonstrate value while improving the lives of patients who need mental health support." The partnership comes at a critical time as healthcare organizations nationwide face increasing demand for behavioral health services, clinician shortages, and pressure to demonstrate measurable outcomes. By providing actionable insights derived from real-world data tailored to specific markets and populations, the Iris Telehealth-Holmusk collaboration will help healthcare leaders navigate these challenges while building more effective and sustainable mental health programs that serve their communities' unique needs. About Iris Telehealth Iris Telehealth partners with healthcare organizations to deliver high-quality, sustainable telepsychiatry and therapy programs. Through its network of licensed behavioral health clinicians and the power of data analytics, Iris provides patient-centered, evidence-based care to those in need. For more information, visit About Holmusk Holmusk is creating the standard for behavioral health with best-in-class real-world data to transform research and behavioral health care. Combining the leading behavioral health database with AI-powered analytics and digital solutions designed to address the most pressing challenges in behavioral health, Holmusk is advancing the frontier of evidence generation and fueling innovation. Holmusk is headquartered in New York, with four additional offices worldwide. For more information, please visit Media Contact PANBlast on behalf of Iris Telehealth [email protected] 317.806.1900 ext. 207 View original content to download multimedia: SOURCE Iris Telehealth
Associated Press
14-04-2025
- Health
- Associated Press
MYndspan Appoints Holmusk Founder and CEO Nawal Roy as Strategic Advisor
Following momentum from its Crowdcube campaign and investment from EMOTIV, MYndspan is deepening its commitment to evidence-based brain health LONDON, April 14, 2025 /PRNewswire/ - MYndspan, the first company to offer clinical-grade MEG brain scanning to consumers, today announced the appointment of Nawal Roy, Founder and CEO of Holmusk, as a strategic advisor. Roy's expertise in behavioral health data science and real-world evidence will help accelerate MYndspan's mission to make measurable brain health accessible to all. This appointment follows the launch of MYndspan's equity crowdfunding campaign on Crowdcube and a strategic investment from global neurotech leader EMOTIV, underscoring MYndspan's commitment to building a consumer-accessible ecosystem for personalized, evidence-based brain health. Ready to take control of your brain health? Be among the first to experience the world's most advanced brain scan at MYndspan's flagship London brain health centre, opening later this year. Featured in The Guardian, Stylist Magazine, and ITV News, MYndspan's MEG-based brain scans are already making headlines. Invest in MYndspan on Crowdcube. Powering Precision Brain Health with the Gold Standard in Behavioral Data Roy is the architect behind NeuroBlu, Holmusk's real-world data platform and the world's largest behavioral health database, housing longitudinal data from over 35 million patients across 30+ health systems. His work has been instrumental in transforming mental health care from subjective assessment to data-driven science. 'MYndspan is building what brain health has long needed: a science-backed, user-accessible way to measure and monitor how our brains are functioning,' said Roy. 'Their use of MEG aligns with Holmusk's goal to apply real-world data and objective metrics to improve mental health outcomes.' Building the Future of Brain Health on a Foundation of Data MYndspan leverages Magnetoencephalography (MEG), the most precise, real-time, non-invasive technology for measuring brain function, to create novel biomarkers such as Functional Brain Age and the Brain Stability Index. Roy's appointment will support the company's efforts to: 'We're bringing together leaders across neuroscience, technology, and behavioral health to build a smarter brain care model,' said Caitlin Baltzer, Co-Founder and CEO of MYndspan. 'Nawal's strategic insight will be instrumental in scaling our evidence-based approach to millions of people.' Positioned to Lead in a $100B+ Market Opportunity Roy's appointment comes as MYndspan prepares to open its flagship London brain health center and expands its commercial partnerships with global leaders including MEGIN, BIOS Health, IMEDCO, and EMOTIV. Together, these partnerships are establishing MYndspan as a hub of precision brain health. With neurological disorders now the world's leading cause of disability, and research showing up to 45% of dementia cases are preventable with early detection, the need for proactive brain health solutions has never been more urgent. Join us in building the data layer of brain health. Invest in MYndspan on Crowdcube and shape the future of preventive brain care, powered by the world's most advanced brain scan and personalized insights. Invest in MYndspan on Crowdcube. About MYndspan MYndspan is on a mission to improve access to preventive and proactive brain health and is the first company in the world to bring non-invasive Magnetoencephalography (MEG) technology directly to the consumer. MEG is typically only accessible in research and specialist clinical settings and is the most advanced method of recording and evaluating the brain while it is actively functioning. MYndspan's brain health assessment technology is informed by 35 years of research and 300+ peer-reviewed studies, and its goal is to become a necessary preventive health measure to support better brain health for all—including the early detection of neurodegenerative conditions and functional abnormalities from invisible traumatic brain injuries and disorders such as depression and PTSD. Website: View original content: SOURCE MYndspan
